| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-641
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G83-003
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G69-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G69-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-451 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-50 |
| filingDate |
2018-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_744bcc684030bd9d9c89bc6bc553c071
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7c732ed8ecb83b7b26d62f17b4c2e289
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9f79164a004840f41584e3a9e063f601
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b80ac37416ffc91b7e95505d0e38d05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ffb0bed616a9bb1a5ddd8488124f272
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_966bba3c1e7a2e0fc5f17b839e88e7d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c2089b6455b99fef32a82b0e1e68903b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89488ea1308bf69588b5df1e6c30ecfa |
| publicationDate |
2018-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
TW-201841659-A |
| titleOfInvention |
Therapeutic dendrimer |
| abstract |
The dendrimer of formula (I) is disclosed: And pharmaceutically acceptable salts thereof. A pharmaceutical composition comprising a dendrimer of formula (I) and a method for treating cancer are also disclosed. |
| priorityDate |
2017-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |